VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and business development for innovative products targeting orphan conditions with major unmet medical need. The company is drawing on the expertise of its founders as it continues to build a portfolio of rare disease medicines while advancing its lead program for Short Bowel Syndrome.
Free account • No credit card • 5 profiles/day
WP Engine is a managed WordPress hosting platform offering fast, secure, and scalable solutions optimized for website performance and security, with expert support and developer tools for seamless website management.
View Companies using WP EngineAdvanced Custom Fields Pro is a powerful WordPress plugin that enables users to easily create, manage, and display custom fields and content layouts, enhancing website flexibility and customization without coding.
View Companies using Advanced Custom Fields ProCodeTwo is a suite of enterprise-grade email management solutions, offering tools for email migration, backup, archiving, and security to enhance productivity and ensure compliance across Microsoft 365 and Exchange environments.
View Companies using CodeTwoAdobe Marketing Cloud is an integrated platform that offers tools for data-driven marketing, analytics, content management, and personalization, enabling businesses to deliver seamless, targeted customer experiences across multiple channels.
View Companies using Adobe Marketing CloudYoast SEO Premium is a powerful WordPress plugin that enhances your website's search engine rankings with advanced SEO tools, keyword optimization, internal linking suggestions, and content insights to boost visibility and traffic.
View Companies using Yoast SEO Premium
Peqlab US
Biotechnology
ZymoGenetics
Biotechnology
Agencourt Bioscience
Biotechnology
Sunset Hotel
Biotechnology
Pangen Biosystems Inc.
biotechnology
Editas Medicine
biotechnology
Who are the decision makers in VectivBio AG?
The decision makers in VectivBio AG are Nader N Youssef, Marie-agnes Bagnard, etc. Click to Find VectivBio AG decision makers emails.
What services does VectivBio AG offer?
VectivBio AG specializes in developing innovative therapies for patients with rare diseases. Their services include drug development, clinical trials, and regulatory support to ensure that their therapies meet the necessary standards for safety and efficacy. They focus on leveraging advanced biotechnological methods to create solutions that address unmet medical needs.
What types of rare diseases does VectivBio target?
VectivBio is dedicated to addressing a variety of rare diseases, particularly those that involve significant unmet medical needs. Their primary focus includes conditions related to metabolic disorders, genetic diseases, and other rare conditions that significantly impact patients' quality of life. The company aims to provide innovative treatments that can improve outcomes for these patients.
How does VectivBio ensure the safety and efficacy of its therapies?
VectivBio follows a rigorous process for ensuring the safety and efficacy of its therapies. This includes conducting preclinical studies, followed by multiple phases of clinical trials that involve careful monitoring of patient responses and side effects. The company adheres to strict regulatory guidelines set by health authorities to ensure that all therapies are thoroughly tested before they are made available to patients.
What is the significance of VectivBio's focus on biotechnology?
VectivBio's focus on biotechnology is significant because it allows the company to develop targeted therapies that can address the underlying causes of rare diseases at a molecular level. By utilizing advanced biotechnological techniques, VectivBio can create more effective and personalized treatment options, which can lead to better patient outcomes and improved quality of life for those affected by rare conditions.
In which regions does VectivBio operate?
VectivBio operates globally, with a focus on regions that have a high demand for innovative therapies for rare diseases. This includes Europe and North America, where they engage with regulatory bodies and healthcare providers to ensure that their therapies reach the patients who need them most. The company is committed to expanding its reach to other regions as it develops its portfolio of therapies.
How can patients and healthcare providers learn more about VectivBio's therapies?
Patients and healthcare providers can learn more about VectivBio's therapies by visiting their official website, where they provide detailed information about their ongoing research, clinical trials, and available therapies. Additionally, healthcare providers can contact VectivBio directly for more specific inquiries or to discuss potential collaborations in the treatment of rare diseases.